| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |